Consumer Protection

WASHINGTON, D.C. – Today, Rep. Hank Johnson (GA-04), ranking member of the House Judiciary Subcommittee on Regulatory Reform, Commercial and Antitrust Law (RRCAL), which exercises jurisdiction over antitrust laws and competition, called on the Federal Communications Commission (FCC) to take swift action to address the disproportionate use of surveillance technology against low-income and minority communities.

Congressman Hank Johnson held a telephone town hall from his Washington, D.C. office on Wednesday, Nov. 16, 2016 from 6:30 to 8 p.m. He called 50,000 residents in the Fourth District to hear their thoughts on the results of the Nov. 8 General Election and to listen to what they would like to see him work on in the 115th Congress that begins Jan. 3, 2017.

WASHINGTON, D.C. – Today, the Federal Trade Commission (FTC) issued a staff report providing an assessment of the regulatory and competition policy implications of sharing economy platforms. The report follows a 2015 June FTC public workshop on the issue.

WASHINGTON, D.C. – On October 27, the Federal Communications Commission (FCC) adopted rules to protect consumers’ privacy for information collected by broadband Internet Service Providers (ISPs). The final rules require greater choice, transparency, and security protection for this information.

WASHINGTON, D.C. – U.S. Representative Henry C. “Hank” Johnson, Jr., (GA-04), the Ranking Member of the Antitrust Subcommittee of the House Judiciary Committee, issued the following statement in response to the proposed acquisition of Time Warner by AT&T:

Agency will now hold public comment period until Dec. 1

LITHONIA, GA – This week, the U.S. Drug Enforcement Agency (DEA) reversed its decision to ban the use of kratom, a plant that researchers say could help fight the opioid epidemic.

On Sept. 30, Congressman Hank Johnson (GA-04) – along with colleague Mark Pocan (WI-02) – penned a letter to U.S. Attorney General Loretta Lynch objecting to the DEA’s hasty decision to classify kratom as a Schedule 1 substance without first going through its normal classification and rulemaking process.